The annexin A2/S100A10 system in health and disease: Emerging paradigms

Nadia Hedhli, Domenick J. Falcone, Bihui Huang, Gabriela Cesarman-Maus, Rosemary Kraemer, Haiyan Zhai, Stella E. Tsirka, Laura Santambrogio, Katherine A. Hajjar

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Since its discovery as a src kinase substrate more than three decades ago, appreciation for the physiologic functions of annexin A2 and its associated proteins has increased dramatically. With its binding partner S100A10 (p11), A2 forms a cell surface complex that regulates generation of the primary fibrinolytic protease, plasmin, and is dynamically regulated in settings of hemostasis and thrombosis. In addition, the complex is transcriptionally upregulated in hypoxia and promotes pathologic neoangiogenesis in the tissues such as the retina. Dysregulation of both A2 and p11 has been reported in examples of rodent and human cancer. Intracellularly, A2 plays a critical role in endosomal repair in postarthroplastic osteolysis, and intracellular p11 regulates serotonin receptor activity in psychiatric mood disorders. In human studies, the A2 system contributes to the coagulopathy of acute promyelocytic leukemia, and is a target of high-titer autoantibodies in patients with antiphospholipid syndrome, cerebral thrombosis, and possibly preeclampsia. Polymorphisms in the human ANXA2 gene have been associated with stroke and avascular osteonecrosis of bone, two severe complications of sickle cell disease. Together, these new findings suggest that manipulation of the annexin A2/S100A10 system may offer promising new avenues for treatment of a spectrum of human disorders.

Original languageEnglish (US)
Article number406273
JournalJournal of Biomedicine and Biotechnology
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Annexin A2
varespladib methyl
Health
src-Family Kinases
Serotonin Receptors
Fibrinolysin
Polymorphism
Autoantibodies
Bone
Repair
Peptide Hydrolases
Genes
Tissue
Intracranial Thrombosis
Acute Promyelocytic Leukemia
Osteolysis
Antiphospholipid Syndrome
Osteonecrosis
Sickle Cell Anemia
Substrates

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Genetics
  • Molecular Biology
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Cite this

Hedhli, N., Falcone, D. J., Huang, B., Cesarman-Maus, G., Kraemer, R., Zhai, H., ... Hajjar, K. A. (2012). The annexin A2/S100A10 system in health and disease: Emerging paradigms. Journal of Biomedicine and Biotechnology, 2012, [406273]. https://doi.org/10.1155/2012/406273

The annexin A2/S100A10 system in health and disease : Emerging paradigms. / Hedhli, Nadia; Falcone, Domenick J.; Huang, Bihui; Cesarman-Maus, Gabriela; Kraemer, Rosemary; Zhai, Haiyan; Tsirka, Stella E.; Santambrogio, Laura; Hajjar, Katherine A.

In: Journal of Biomedicine and Biotechnology, Vol. 2012, 406273, 2012.

Research output: Contribution to journalArticle

Hedhli, N, Falcone, DJ, Huang, B, Cesarman-Maus, G, Kraemer, R, Zhai, H, Tsirka, SE, Santambrogio, L & Hajjar, KA 2012, 'The annexin A2/S100A10 system in health and disease: Emerging paradigms', Journal of Biomedicine and Biotechnology, vol. 2012, 406273. https://doi.org/10.1155/2012/406273
Hedhli, Nadia ; Falcone, Domenick J. ; Huang, Bihui ; Cesarman-Maus, Gabriela ; Kraemer, Rosemary ; Zhai, Haiyan ; Tsirka, Stella E. ; Santambrogio, Laura ; Hajjar, Katherine A. / The annexin A2/S100A10 system in health and disease : Emerging paradigms. In: Journal of Biomedicine and Biotechnology. 2012 ; Vol. 2012.
@article{b2ed291c288f42beb89c03d603307dc7,
title = "The annexin A2/S100A10 system in health and disease: Emerging paradigms",
abstract = "Since its discovery as a src kinase substrate more than three decades ago, appreciation for the physiologic functions of annexin A2 and its associated proteins has increased dramatically. With its binding partner S100A10 (p11), A2 forms a cell surface complex that regulates generation of the primary fibrinolytic protease, plasmin, and is dynamically regulated in settings of hemostasis and thrombosis. In addition, the complex is transcriptionally upregulated in hypoxia and promotes pathologic neoangiogenesis in the tissues such as the retina. Dysregulation of both A2 and p11 has been reported in examples of rodent and human cancer. Intracellularly, A2 plays a critical role in endosomal repair in postarthroplastic osteolysis, and intracellular p11 regulates serotonin receptor activity in psychiatric mood disorders. In human studies, the A2 system contributes to the coagulopathy of acute promyelocytic leukemia, and is a target of high-titer autoantibodies in patients with antiphospholipid syndrome, cerebral thrombosis, and possibly preeclampsia. Polymorphisms in the human ANXA2 gene have been associated with stroke and avascular osteonecrosis of bone, two severe complications of sickle cell disease. Together, these new findings suggest that manipulation of the annexin A2/S100A10 system may offer promising new avenues for treatment of a spectrum of human disorders.",
author = "Nadia Hedhli and Falcone, {Domenick J.} and Bihui Huang and Gabriela Cesarman-Maus and Rosemary Kraemer and Haiyan Zhai and Tsirka, {Stella E.} and Laura Santambrogio and Hajjar, {Katherine A.}",
year = "2012",
doi = "10.1155/2012/406273",
language = "English (US)",
volume = "2012",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - The annexin A2/S100A10 system in health and disease

T2 - Emerging paradigms

AU - Hedhli, Nadia

AU - Falcone, Domenick J.

AU - Huang, Bihui

AU - Cesarman-Maus, Gabriela

AU - Kraemer, Rosemary

AU - Zhai, Haiyan

AU - Tsirka, Stella E.

AU - Santambrogio, Laura

AU - Hajjar, Katherine A.

PY - 2012

Y1 - 2012

N2 - Since its discovery as a src kinase substrate more than three decades ago, appreciation for the physiologic functions of annexin A2 and its associated proteins has increased dramatically. With its binding partner S100A10 (p11), A2 forms a cell surface complex that regulates generation of the primary fibrinolytic protease, plasmin, and is dynamically regulated in settings of hemostasis and thrombosis. In addition, the complex is transcriptionally upregulated in hypoxia and promotes pathologic neoangiogenesis in the tissues such as the retina. Dysregulation of both A2 and p11 has been reported in examples of rodent and human cancer. Intracellularly, A2 plays a critical role in endosomal repair in postarthroplastic osteolysis, and intracellular p11 regulates serotonin receptor activity in psychiatric mood disorders. In human studies, the A2 system contributes to the coagulopathy of acute promyelocytic leukemia, and is a target of high-titer autoantibodies in patients with antiphospholipid syndrome, cerebral thrombosis, and possibly preeclampsia. Polymorphisms in the human ANXA2 gene have been associated with stroke and avascular osteonecrosis of bone, two severe complications of sickle cell disease. Together, these new findings suggest that manipulation of the annexin A2/S100A10 system may offer promising new avenues for treatment of a spectrum of human disorders.

AB - Since its discovery as a src kinase substrate more than three decades ago, appreciation for the physiologic functions of annexin A2 and its associated proteins has increased dramatically. With its binding partner S100A10 (p11), A2 forms a cell surface complex that regulates generation of the primary fibrinolytic protease, plasmin, and is dynamically regulated in settings of hemostasis and thrombosis. In addition, the complex is transcriptionally upregulated in hypoxia and promotes pathologic neoangiogenesis in the tissues such as the retina. Dysregulation of both A2 and p11 has been reported in examples of rodent and human cancer. Intracellularly, A2 plays a critical role in endosomal repair in postarthroplastic osteolysis, and intracellular p11 regulates serotonin receptor activity in psychiatric mood disorders. In human studies, the A2 system contributes to the coagulopathy of acute promyelocytic leukemia, and is a target of high-titer autoantibodies in patients with antiphospholipid syndrome, cerebral thrombosis, and possibly preeclampsia. Polymorphisms in the human ANXA2 gene have been associated with stroke and avascular osteonecrosis of bone, two severe complications of sickle cell disease. Together, these new findings suggest that manipulation of the annexin A2/S100A10 system may offer promising new avenues for treatment of a spectrum of human disorders.

UR - http://www.scopus.com/inward/record.url?scp=84869059089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869059089&partnerID=8YFLogxK

U2 - 10.1155/2012/406273

DO - 10.1155/2012/406273

M3 - Article

C2 - 23193360

AN - SCOPUS:84869059089

VL - 2012

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 406273

ER -